HOME >> BIOLOGY >> NEWS
Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health

WHAT

Victoria Hale, founder and CEO of the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., will speak at the BIO 2004 Annual International Convention in the Global Health track during a breakout session titled Mutually Inclusive: New and Affordable Drugs for Developed, Developing Worlds.

The session will highlight how a collaboration among industry, new nonprofits and other public sector groups might enable drug companies to maximize their assets and underutilized intellectual property without compromising their profitability goals. At the same time, such collaborations could demonstrate greater corporate social responsibility and result in affordable new drugs for diseases of the developing world, with application for commercial drugs for the developed world.

Chair: Tom Brewer, Senior Project Officer, Bill & Melinda Gates Foundation
Speakers: Victoria Hale, CEO, Institute for OneWorld Health; Chris Hentschel, CEO, Medicines for Malaria Venture; Lynn Marks, Senior Vice President, GlaxoSmithKline; Wendy Taylor, Executive Director, BIO Ventures for Global Health

OneWorld Health will also participate in the International Biotechnology Marketplace and will sponsor a booth at the annual convention. OneWorld Health advances global health by developing new, affordable medicines for infectious diseases that disproportionately affect people in the developing world. More information is available at www.oneworldhealth.org

WHEN

Breakout Session: June 7, 2004, 2:15 PM - 3:45 PM
International Biotechnology Marketplace: June 6, 2004, 12:00 - 5:30 PM
Booth: June 7-9 from 9: 15 AM at BIO 2004 Annual International Convention

WHERE

Breakout Session: Moscone Convention Center, Room #2007 West
International Biotechnology Marketplace: San Francisco Marriott, Yerba
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
24-May-2004


Page: 1 2

Related biology news :

1. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
2. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
3. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
4. Institute for OneWorld Health nominated for the 2004 World Technology Awards
5. UNC researchers awarded $8.65 million from National Institute on Aging
6. Institute for OneWorld Health receives Gates Foundation grant
7. Lupus Research Institute awards $3 million in novel research grants to further new science in lupus
8. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
9. Institute for OneWorld Health CEO advocates focus first on developing world markets
10. Institute for Systems Biology, Pacific Northwest National Laboratory announce collaboration
11. Harvard Stem Cell Institute hosts inaugural symposia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today announced a ... Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of ... a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions ... as MediVet Biologics since its formation in 2016, the company is relaunching itself under ... build on its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... CAMBRIDGE, Mass. and SOMERSET, N.J (PRWEB) , ... ... ... a leading genome editing company, and Catalent, the leading global provider of advanced ... and consumer health products, today announced that they have entered into a strategic ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... After research ... The completion of a great surgery is only the beginning of a successful study, ... research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
Breaking Biology Technology:
Cached News: